Sugi Predict

Sugi Predict / Compounds / SCHEMBL4140138

SCHEMBL4140138

SCHEMBL4140138

Cc1c(-c2ccc(O)cc2)[nH]c2ccc3[nH]c(=O)cc(Cl)c3c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 2/20 0.44
▸ NR1I2 O75469 1/20 0.42
▸ KDM4E B2RXH2 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ GAA P10253 3/20 0.41
▸ HPGD P15428 2/20 0.41
▸ GLA P06280 1/20 0.41
▸ AR P10275 2/20 0.40
▸ CCNB2 O95067 1/20 0.40
▸ CDK1 P06493 1/20 0.40
▸ CCNB1 P14635 1/20 0.40
▸ GSK3A P49840 1/20 0.40
▸ GSK3B P49841 1/20 0.40
▸ CDK5 Q00535 1/20 0.40
▸ CDK5R1 Q15078 1/20 0.40
▸ CCNB3 Q8WWL7 1/20 0.40
▸ TNKS2 Q9H2K2 2/20 0.40
▸ ALOX5 P09917 1/20 0.40
▸ ERN1 O75460 1/20 0.40
▸ ESR1 P03372 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4143949 0.89 LMNA (0.46) KDM4EARCCNB2CDK1CCNB1
SCHEMBL4148107 0.87 HPGD (0.47) KIF11KDM4EALDH1A1HPGDAR
SCHEMBL4145440 0.86 TNKS2 (0.47) ARTNKS2LMNACYP1A2CYP2C19
SCHEMBL4144971 0.84 MEN1 (0.42) KDM4EGAAARTNKS2ALOX5
SCHEMBL4140109 0.84 MAOA (0.44) KDM4EALDH1A1GAAHPGDAR
SCHEMBL4142870 0.83 AR (0.46) KIF11ARTNKS2LMNAMAPT
SCHEMBL4146511 0.81 LMNA (0.44) ARALOX5LMNAMEN1KMT2A
SCHEMBL4146476 0.78 CSNK1D (0.41) KIF11KDM4EGAAHPGDAR
SCHEMBL4144687 0.78 AR (0.46) ARGSK3BTNKS2LMNACYP1A2
SCHEMBL4131665 0.76 AR (0.47) KDM4EALDH1A1GAAHPGDAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1891067-B1 ANDROGEN RECEPTOR MODULATOR COMPOUNDS AND METHODS LIGAND PHARM INC (US) 2016-01-13 — — EP disclosed
US-8580811-B2 Androgen receptor modulator methods LIGAND PHARMACEUTICALS INCORPORATED (US) 2013-11-12 — — US disclosed
US-20120165362-A1 Androgen receptor modulator compounds and methods LIGAND PHARMACEUTICALS INCORPORATED 2012-06-28 — — US disclosed
US-8193357-B2 Androgen receptor modulator compounds LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-06-05 — — US disclosed
US-20090264455-A9 Androgen Receptor Modulator Compounds and Methods LIGAND PHARMACEUTICALS INCORPORATED (US) 2009-10-22 — — US disclosed
US-20090030027-A1 Androgen Receptor Modulator Compounds and Methods LIGAND PHARMACEUTICALS INCORPORATED (US) 2009-01-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030027-A1 Androgen Receptor Modulator Compounds and Methods AR, NR5A1, ESRRA KIF11 4255/4885NR1I2 61/4885KDM4E 1807/4885
US-20120165362-A1 Androgen receptor modulator compounds and methods AR, NR5A1, ESRRA KIF11 4255/4885NR1I2 61/4885KDM4E 1807/4885
US-20090264455-A9 Androgen Receptor Modulator Compounds and Methods AR, NR5A1, ESRRA KIF11 4255/4885NR1I2 61/4885KDM4E 1807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.